{"id":256007,"date":"2025-08-06T11:31:36","date_gmt":"2025-08-06T09:31:36","guid":{"rendered":"https:\/\/health.saypro.online\/index.php\/2025\/08\/06\/saypro-migraine-management-guidelines-3\/"},"modified":"2025-08-13T11:30:04","modified_gmt":"2025-08-13T09:30:04","slug":"saypro-migraine-management-guidelines-3","status":"publish","type":"post","link":"https:\/\/health.neftaly.net\/index.php\/2025\/08\/06\/saypro-migraine-management-guidelines-3\/","title":{"rendered":"Neftaly Migraine Management Guidelines"},"content":{"rendered":"\n

Neftaly Migraine Management Guidelines<\/strong><\/h1>\n\n\n\n

1. Introduction<\/strong><\/h2>\n\n\n\n

Migraine is a common and disabling neurological disorder that affects people of all ages and backgrounds. It is characterized by recurring headaches, often accompanied by nausea, vomiting, and sensitivity to light or sound.<\/p>\n\n\n\n

The Neftaly Migraine Management Guidelines<\/strong> aim to provide healthcare providers with a standardized, evidence-based approach for the diagnosis, treatment, and long-term management<\/strong> of migraines. These guidelines are tailored for both primary care and community health settings to ensure accessible and effective care for all patients.<\/p>\n\n\n\n

\n\n\n\n

2. Objectives<\/strong><\/h2>\n\n\n\n
    \n
  • Improve accurate diagnosis of migraine in diverse clinical settings<\/li>\n\n\n\n
  • Guide evidence-based acute and preventive treatment<\/li>\n\n\n\n
  • Reduce migraine frequency, severity, and impact on quality of life<\/li>\n\n\n\n
  • Promote patient education and self-management<\/li>\n\n\n\n
  • Ensure safe referral of complex or refractory cases<\/li>\n<\/ul>\n\n\n\n
    \n\n\n\n

    3. Understanding Migraine<\/strong><\/h2>\n\n\n\n

    3.1 Types of Migraine<\/strong><\/h3>\n\n\n\n
    Type<\/strong><\/th>Description<\/strong><\/th><\/tr><\/thead>
    Migraine without Aura<\/strong><\/td>Most common type; moderate to severe pulsating headache, often one-sided, with nausea and sensitivity to light\/sound.<\/td><\/tr>
    Migraine with Aura<\/strong><\/td>Headache preceded by reversible visual, sensory, or speech disturbances.<\/td><\/tr>
    Chronic Migraine<\/strong><\/td>Headache occurring \u226515 days\/month for \u22653 months, with features of migraine on \u22658 days\/month.<\/td><\/tr>
    Menstrual Migraine<\/strong><\/td>Occurs around menstruation, often without aura.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

    3.2 Common Triggers<\/strong><\/h3>\n\n\n\n
      \n
    • Stress or emotional disturbance<\/li>\n\n\n\n
    • Hormonal changes<\/li>\n\n\n\n
    • Skipped meals or dehydration<\/li>\n\n\n\n
    • Certain foods (e.g., aged cheese, chocolate, caffeine)<\/li>\n\n\n\n
    • Bright lights or loud noise<\/li>\n\n\n\n
    • Sleep disturbances<\/li>\n\n\n\n
    • Weather changes<\/li>\n<\/ul>\n\n\n\n
      \n\n\n\n

      4. Diagnostic Criteria (ICHD-3)<\/strong><\/h2>\n\n\n\n

      Migraine without Aura:<\/strong><\/p>\n\n\n\n

        \n
      • At least 5 attacks<\/strong> fulfilling the following:\n
          \n
        • Lasts 4\u201372 hours<\/strong><\/li>\n\n\n\n
        • At least 2 of the following<\/strong>: unilateral, pulsating, moderate to severe, aggravated by activity<\/li>\n\n\n\n
        • At least 1 of the following<\/strong>: nausea\/vomiting or photophobia\/phonophobia<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n

          Migraine with Aura:<\/strong><\/p>\n\n\n\n

            \n
          • At least 2 attacks<\/strong> with:\n
              \n
            • Fully reversible aura symptoms (visual, sensory, speech)<\/li>\n\n\n\n
            • At least 1 aura symptom develops gradually<\/strong> over \u22655 minutes<\/li>\n\n\n\n
            • Headache begins during or within 60 minutes after aura<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n
              \n\n\n\n

              5. Acute Migraine Management<\/strong><\/h2>\n\n\n\n

              5.1 First-Line Treatments<\/strong><\/h3>\n\n\n\n
                \n
              • Mild to Moderate:<\/strong>\n
                  \n
                • Paracetamol (1000 mg)<\/li>\n\n\n\n
                • NSAIDs (e.g., Ibuprofen 400\u2013600 mg or Naproxen 500 mg)<\/li>\n<\/ul>\n<\/li>\n\n\n\n
                • Moderate to Severe or Non-Responsive to First-Line:<\/strong>\n
                    \n
                  • Triptans<\/strong> (e.g., Sumatriptan 50\u2013100 mg oral or 6 mg SC)<\/li>\n\n\n\n
                  • Combination therapy<\/strong>: Triptan + NSAID<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n

                    5.2 Adjunctive Treatments<\/strong><\/h3>\n\n\n\n
                      \n
                    • Antiemetics: Metoclopramide 10 mg or Domperidone 10 mg<\/li>\n\n\n\n
                    • Adequate hydration and rest in a quiet, dark room<\/li>\n<\/ul>\n\n\n\n

                      5.3 Avoid Overuse<\/strong><\/h3>\n\n\n\n
                        \n
                      • Limit use of acute medications to \u22642 days\/week<\/strong> to prevent medication-overuse headache (MOH)<\/li>\n<\/ul>\n\n\n\n
                        \n\n\n\n

                        6. Preventive (Prophylactic) Treatment<\/strong><\/h2>\n\n\n\n

                        When to Start Preventive Therapy:<\/strong><\/h3>\n\n\n\n
                          \n
                        • \u22654 migraine days\/month<\/li>\n\n\n\n
                        • Significant disability despite acute treatment<\/li>\n\n\n\n
                        • Contraindications to acute therapies<\/li>\n\n\n\n
                        • Preference of the patient<\/li>\n<\/ul>\n\n\n\n

                          Common Preventive Medications:<\/strong><\/h3>\n\n\n\n
                          Drug Class<\/strong><\/th>Examples<\/strong><\/th>Notes<\/strong><\/th><\/tr><\/thead>
                          Beta-blockers<\/td>Propranolol, Metoprolol<\/td>Avoid in asthma, bradycardia<\/td><\/tr>
                          Antidepressants<\/td>Amitriptyline, Nortriptyline<\/td>Useful if coexisting depression or insomnia<\/td><\/tr>
                          Anticonvulsants<\/td>Topiramate, Valproate<\/td>Caution in pregnancy<\/td><\/tr>
                          CGRP Inhibitors<\/td>Erenumab, Fremanezumab<\/td>For refractory cases, costly<\/td><\/tr>
                          Calcium Channel Blockers<\/td>Verapamil<\/td>Sometimes used off-label<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

                          Start low, go slow<\/strong> \u2014 monitor for side effects and effectiveness. Treatment trial should last at least 2\u20133 months before assessing benefit.<\/p>\n\n\n\n

                          \n\n\n\n

                          7. Non-Pharmacological Management<\/strong><\/h2>\n\n\n\n

                          7.1 Lifestyle Modifications<\/strong><\/h3>\n\n\n\n
                            \n
                          • Regular sleep, meals, and exercise<\/li>\n\n\n\n
                          • Hydration and caffeine moderation<\/li>\n\n\n\n
                          • Identify and avoid personal triggers<\/li>\n\n\n\n
                          • Stress reduction techniques: mindfulness, yoga, breathing exercises<\/li>\n<\/ul>\n\n\n\n

                            7.2 Behavioral Therapies<\/strong><\/h3>\n\n\n\n
                              \n
                            • Cognitive Behavioral Therapy (CBT)<\/li>\n\n\n\n
                            • Biofeedback or relaxation therapy<\/li>\n\n\n\n
                            • Patient migraine diaries for trigger tracking<\/li>\n<\/ul>\n\n\n\n
                              \n\n\n\n

                              8. Migraine in Special Populations<\/strong><\/h2>\n\n\n\n

                              8.1 Pregnancy and Breastfeeding<\/strong><\/h3>\n\n\n\n
                                \n
                              • Prefer paracetamol<\/strong> for acute treatment<\/li>\n\n\n\n
                              • Avoid NSAIDs (especially in 3rd trimester) and most triptans<\/li>\n\n\n\n
                              • Preventive treatment discouraged unless necessary; non-drug strategies preferred<\/strong><\/li>\n<\/ul>\n\n\n\n

                                8.2 Children and Adolescents<\/strong><\/h3>\n\n\n\n
                                  \n
                                • Use weight-appropriate doses of ibuprofen or paracetamol<\/li>\n\n\n\n
                                • Lifestyle modifications crucial<\/li>\n\n\n\n
                                • Avoid adult-specific preventives unless guided by a specialist<\/li>\n<\/ul>\n\n\n\n
                                  \n\n\n\n

                                  9. Referral Guidelines<\/strong><\/h2>\n\n\n\n

                                  Refer to a neurologist or headache specialist if:<\/p>\n\n\n\n

                                    \n
                                  • Diagnosis is uncertain (e.g., red flags suggesting secondary causes)<\/li>\n\n\n\n
                                  • Severe or disabling migraines despite treatment<\/li>\n\n\n\n
                                  • Chronic migraine or medication-overuse headache<\/li>\n\n\n\n
                                  • Neurological symptoms (e.g., weakness, confusion) during aura<\/li>\n\n\n\n
                                  • Need for advanced therapy (e.g., CGRP inhibitors, Botox)<\/li>\n<\/ul>\n\n\n\n
                                    \n\n\n\n

                                    10. Red Flags: “SNOOP” for Secondary Headaches<\/strong><\/h2>\n\n\n\n
                                    Red Flag<\/strong><\/th>Indicator<\/strong><\/th><\/tr><\/thead>
                                    S<\/strong> \u2013 Systemic<\/td>Fever, weight loss, cancer, HIV<\/td><\/tr>
                                    N<\/strong> \u2013 Neurological signs<\/td>Confusion, weakness, visual changes<\/td><\/tr>
                                    O<\/strong> \u2013 Onset<\/td>Sudden or thunderclap headache<\/td><\/tr>
                                    O<\/strong> \u2013 Older age<\/td>First onset after age 50<\/td><\/tr>
                                    P<\/strong> \u2013 Pattern change<\/td>Progressively worsening or new type<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

                                    Urgent evaluation (CT\/MRI) needed if any red flags are present.<\/p>\n\n\n\n

                                    \n\n\n\n

                                    11. Patient Education and Support<\/strong><\/h2>\n\n\n\n
                                      \n
                                    • Teach patients to:\n
                                        \n
                                      • Recognize early signs of migraine<\/li>\n\n\n\n
                                      • Maintain a headache diary<\/li>\n\n\n\n
                                      • Use medications correctly<\/li>\n\n\n\n
                                      • Understand the importance of preventive measures<\/li>\n<\/ul>\n<\/li>\n\n\n\n
                                      • Provide written action plans and emergency contacts<\/li>\n<\/ul>\n\n\n\n
                                        \n\n\n\n

                                        12. Monitoring and Evaluation<\/strong><\/h2>\n\n\n\n
                                          \n
                                        • Assess frequency, severity, and impact of migraine monthly<\/li>\n\n\n\n
                                        • Use tools like:\n
                                            \n
                                          • MIDAS (Migraine Disability Assessment)<\/strong><\/li>\n\n\n\n
                                          • HIT-6 (Headache Impact Test)<\/strong><\/li>\n<\/ul>\n<\/li>\n\n\n\n
                                          • Adjust treatment based on response and side effects<\/li>\n<\/ul>\n\n\n\n
                                            \n\n\n\n

                                            13. Conclusion<\/strong><\/h2>\n\n\n\n

                                            Migraine is manageable with the right combination of medication, lifestyle, and education. Neftaly\u2019s Migraine Management Guidelines empower frontline healthcare workers to deliver effective, compassionate, and timely care \u2014 reducing the burden of migraines on individuals, families, and health systems.<\/p>\n\n\n\n

                                            \n\n\n\n

                                            For clinical tools, referral protocols, or training support, contact the Neftaly Neurology and Non-Communicable Disease Unit.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

                                            Neftaly Migraine Management Guidelines 1. Introduction Migraine is a common and disabling neurological disorder that affects people of all ages and backgrounds. It is characterized by recurring headaches, often accompanied by nausea, vomiting, and sensitivity to light or sound. The Neftaly Migraine Management Guidelines aim to provide healthcare providers with a standardized, evidence-based approach for […]<\/p>\n","protected":false},"author":20,"featured_media":391881,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[382,171,9633,4],"class_list":["post-256007","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saypro-health-insights","tag-guidelines","tag-management","tag-migraine","tag-saypro"],"_links":{"self":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts\/256007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/comments?post=256007"}],"version-history":[{"count":0,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts\/256007\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/media\/391881"}],"wp:attachment":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/media?parent=256007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/categories?post=256007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/tags?post=256007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}